Antioxidant therapy after a first heart attack
Part of Heart & circulation clinical trials.
This trial tests whether giving a combination of antioxidant vitamins (supplements) during emergency treatment for a first heart attack can reduce heart muscle damage and improve recovery. You might be eligible if you are having an emergency angioplasty for a recent heart attack.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- This is your first heart attack, and the pain started within the last 6 hours.
- You are having a procedure to open the blocked artery (angioplasty with stent) soon.
- You have not had prior heart surgery or a pacemaker/implantable defibrillator.
- You have no severe kidney disease, liver cirrhosis, or advanced heart failure.
- You can have an MRI of the heart (no claustrophobia or other MRI restrictions).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well the heart muscle recovers after emergency angioplasty (a procedure to open blocked arteries) in people having their first major heart attack. It uses special heart scans and ECGs to check blood flow and muscle health, aiming to improve future treatments.
This study uses advanced CT scans and blood tests to look at how the heart is damaged and recovers after a first heart attack. It may help doctors find better ways to treat heart attacks in the future.
This trial tests whether patients who have had a heart attack with a specific type of artery blockage can be safely treated without placing a metal stent (tube) in their artery. Doctors will monitor whether the blockage stays open on its own.
This study uses advanced heart scans (MRI) before and after a common artery-opening procedure to see how the heart heals. It only includes people having their first heart attack who get emergency treatment with a stent.
This trial tests a heart medication (a cardio-selective beta-blocker) given during a heart attack to see if it reduces damage to the heart muscle. It might help people having their first heart attack who are treated quickly with angioplasty (a procedure to open blocked arteries).
This trial tests a new drug given shortly after a first heart attack to see if it can reduce heart damage when blood flow is restored. It is for patients having a specific type of heart attack (STEMI) and getting a procedure to open the blocked artery within 6 hours of symptoms starting.
Hear when a new Acute Myocardial Infarction (AMI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.